scispace - formally typeset
K

Kenji Takabayashi

Researcher at University of California, San Diego

Publications -  62
Citations -  6785

Kenji Takabayashi is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Immune system & Antigen. The author has an hindex of 30, co-authored 62 publications receiving 6669 citations. Previous affiliations of Kenji Takabayashi include Novartis.

Papers
More filters
Journal ArticleDOI

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

TL;DR: Polymerase chain reaction and Southern blot analysis confirmed the frequent deletion or rearrangement of the CDK4-inhibitor gene in melanomas, gliomas, lung cancers and leukaemias, and the absence of detectable gene transcripts.
Journal ArticleDOI

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

TL;DR: The protective effects of Probiotics are mediated by their own DNA rather than by their metabolites or ability to colonize the colon, and live microorganisms are not required to attenuate experimental colitis because nonviable probiotics are equally effective.
Journal ArticleDOI

Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity

TL;DR: Amb a 1-ISS conjugate has an enhanced T(H)1-biased immunogenicity and reduced allergenicity, and may offer a more effective and safer approach for allergenic immunotherapy than currently available methods.
Journal Article

Inhibition of TNF-alpha expression by adenosine: role of A3 adenosine receptors.

TL;DR: In this article, the authors studied the human macrophage cell line U937 to determine the adenosine receptor subtypes responsible and the intracellular signaling mechanisms involved.
Journal ArticleDOI

Immunostimulatory DNA ameliorates experimental and spontaneous murine colitis

TL;DR: In all models of experimental and spontaneous colitis examined, ISS-ODN administration ameliorated clinical, biochemical, and histologic scores of colonic inflammation and suggest a physiologic, anti-inflammatory role for immunostimulatory DNA in the GI tract.